User's blog

Author: Paramraj Singh Sondhi

  • Accepting or Rejecting Applicants

    Once a participant has been matched to your clinical trial through the DecenTrialz pre-screening process, your research site is responsible for determining whether to accept the match for referral and further contact or decline the applicant based on available information. This decision must be based on preliminary eligibility alignment and in accordance with your IRB-approved procedures.

    This section outlines how to accept or reject matched participants, the associated responsibilities, and the documentation expectations that support compliance, transparency, and participant respect.

    What Does ‘Accepting an Applicant’ Mean?

    Accepting an applicant on the DecenTrialz platform means your site:

    • Acknowledges that the matched participant appears to preliminarily meet the trial’s inclusion/exclusion criteria
    • Agrees to initiate direct outreach or formal screening follow-up
    • Accepts responsibility for safeguarding the participant’s contact information and ensuring IRB-compliant communication

    Note: Accepting an applicant does not mean the participant is enrolled. It simply advances the process toward further screening and consent, as determined by your internal SOPs.

    What Does ‘Rejecting an Applicant’ Mean?

    Rejecting an applicant means that, based on pre-screening information:

    • The participant does not meet key eligibility criteria
    • The trial is no longer recruiting at your site
    • The site has reached enrollment capacity
    • The participant falls outside of geographic or logistical constraints (e.g., unwilling to travel)

    Rejecting a participant:

    • Does not notify the participant directly
    • Does not impact their ability to match to other studies
    • Must be documented with an appropriate reason code (see below)

    FAQ: Will the participant know they’ve been rejected?

    No. Participants are not directly notified if they are declined. However, they may be eligible for other trials in the future.

    How to Accept or Reject a Matched Participant

    Site personnel with appropriate access (e.g., Site Administrator, Study Coordinator) can manage applicants via the Match Dashboard:

    Accepting a Participant:

    1. Click on the participant record in the Match Dashboard.
    2. Select “Accept for Outreach” or “Refer to Site Team.”
    3. Confirm assignment to a responsible user (e.g., CRC or PI).
    4. Securely unlock contact details for follow-up.
    5. Log the intended method of communication (e.g., phone, email).

    Rejecting a Participant:

    1. Click on the participant record.
    2. Select “Reject Match.”
    3. Choose a reason from the predefined dropdown list:
      • Does not meet age/gender criteria
      • Ineligible condition or medical history
      • Site not enrolling at this time
      • Travel limitations or site location mismatch
      • Duplicate or repeated match
      • Other (with optional free-text comment)
    4. Submit and finalize decision, the match will be archived for compliance logging.

    Participant Communication Post-Acceptance

    Once a participant is accepted:

    • Their contact information becomes visible to the assigned user
    • The site is responsible for initiating IRB-approved outreach
    • Initial contact attempts must be documented within the platform
    • All communication must comply with:
      • Your IRB’s consent and script guidelines
      • Institutional communication policies
      • HIPAA and participant privacy protocols

    If the participant does not respond after multiple attempts, the status can be marked as “No Response” with corresponding time-stamped logs.

    Responsibility & Documentation Requirements

    Every action taken on a matched applicant must be:

    • Performed by an authorized user
    • Time-stamped and linked to the user ID
    • Justified with an action reason (for audit traceability)
    • Logged automatically in the platform’s compliance audit trail

    Sites may export match outcome summaries for:

    • Internal SOP review
    • Sponsor feasibility reports
    • Regulatory audits or IRB reviews

    When to Escalate or Hold a Decision

    If a participant’s match is borderline or if there is uncertainty regarding:

    • Interpretation of eligibility
    • IRB language for outreach
    • Documentation completeness

    The site may mark the record as “On Hold” and:

    • Escalate internally to the PI or Regulatory Officer
    • Request clarification from DecenTrialz Support
    • Await pending IRB approval or protocol amendment

    Participants on hold will not be contacted until a decision is logged.

    Key Note: Accepting or rejecting a participant is not merely a technical step, it is a regulatory decision point. Each action must be intentional, compliant, and clearly documented. Sites are expected to treat every match with professional discretion, protect participant confidentiality, and act only within the boundaries of approved study criteria and ethical standards.

  • Understanding Your Dashboard

    The Site Performance Dashboard on DecenTrialz provides real-time insights into participant engagement, recruitment effectiveness, referral progress, and site-specific activity. This centralized view helps Principal Investigators (PIs), Site Coordinators, and Research Administrators make informed operational decisions while ensuring compliance with sponsor expectations and regulatory benchmarks.

    This section provides a comprehensive overview of the dashboard’s features, data visualization tools, interpretation guidance, and role-based visibility settings.

    Purpose of the Dashboard

    The dashboard is designed to:

    • Present a real-time view of participant activity across all live and draft trials hosted by your site
    • Highlight trends in eligibility, referral, and outreach outcomes
    • Surface bottlenecks or drop-offs in the pre-screening process
    • Support recruitment planning and capacity forecasting
    • Facilitate internal and sponsor reporting through exportable charts and tables

    It functions as a mission control panel for your site’s performance on the DecenTrialz platform.

    Key Metrics Displayed

    Each dashboard is tailored to your site’s user role (e.g., Admin, Coordinator, PI) and includes the following data panels:

    MetricWhat It ShowsHow to Use It
    Trial Status SummaryNumber of trials in Draft, Live, Paused, or Closed statusTrack activation pipeline and active enrollment periods
    Pre-Screeners CompletedTotal and per-trial breakdownIdentify trials with strong vs. weak engagement
    Eligibility Pass Rate% of participants who met inclusion/exclusion criteriaAdjust outreach messaging or site targeting if needed
    Referral ActivityCount of participants referred, with time stampsAssess time-to-referral and team responsiveness
    Participant DispositionOutcome of each referral (Interested, Declined, No Show)Improve follow-up workflows and participant communication
    Avg. Time to Review Pre-ScreenerTime between participant submission and site reviewOptimize site staffing or auto-reminders if delays occur
    Outreach Attempts LoggedNumber of site-initiated contact attempts (no PHI)Monitor follow-through by coordinator teams

    Note: All displayed data is de-identified by default. Participant-level views are accessible only to users with appropriate role permissions and after referral.

    Interactive Features

    The dashboard is not static, users can interact with charts and filter data based on:

    • Trial (individual or grouped view)
    • Date range (e.g., last 7 days, monthly, custom)
    • Coordinator activity (to monitor internal performance)
    • Referral status (to track participant flow stage-by-stage)

    You can also click on any chart element (e.g., a data bar or trendline) to drill down into the specific data table powering that visualization.

    Role-Based Access

    To ensure data security and ethical transparency, dashboard access is governed by user role:

    RoleView Level
    Site AdminFull access to all trials, metrics, and user performance
    Study CoordinatorAccess to assigned trials and participant interactions only
    PI / InvestigatorFull trial-level visibility but cannot modify admin settings
    Sponsor Liaison (if granted)Read-only, de-identified data view for performance audits

    If a staff member changes roles or responsibilities, site administrators can update permissions via the Admin Panel → User Management section.

    Exporting Data for Internal Use or Sponsor Review

    You may export dashboard data in multiple formats:

    • CSV: For spreadsheets or internal performance trackers
    • PDF: For sponsor presentations or IRB reports
    • Dashboard Snapshot: Save current screen as a visual (for briefings)

    Exports are watermarked with trial and site ID for version control and stored securely in your Reporting Archive tab.

    Troubleshooting Dashboard Discrepancies

    If you notice incorrect, missing, or outdated information on your dashboard:

    1. Check your date filters and ensure the correct trial is selected.
    2. Confirm your user role allows access to the trial or metric in question.
    3. Use the “Refresh Dashboard” button to pull the latest data.

    FAQ: What if our site changes Principal Investigators (PI)?
    Update the PI in your site settings and notify DecenTrialz Support. IRB documentation for the new PI will be required to maintain compliance.

    If issues persist, contact DecenTrialz Support at support@decentrialz.com with your Site ID and a screenshot of the problem.

    Key Note: Your dashboard is not just a reporting tool, it’s an operational command center. Use it to anticipate problems, validate success, and maintain regulatory readiness. Data visibility supports better recruitment planning, faster decisions, and more effective site management.

  • Digital Audit Trails

    In clinical research, accurate documentation is not only a regulatory requirement but also a foundational aspect of ethical trial conduct. Digital audit trails within the DecenTrialz platform ensure that all participant-related actions, data access, and communication events are transparently recorded, time-stamped, and traceable.

    This section outlines how audit trails are maintained, what actions are tracked, who has access to audit logs, and how they support regulatory compliance for sites, sponsors, and IRBs.

    What Is a Digital Audit Trail?

    A digital audit trail is an automated, system-generated log that records the who, what, when, and how of every significant action taken within the platform.

    These logs are:

    • Immutable (cannot be edited after recording)
    • Time-stamped with date and time
    • Linked to specific user accounts and site roles
    • Stored securely in accordance with 21 CFR Part 11 and HIPAA standards

    Purpose: To provide complete accountability, support internal QA/QC, and enable defensible evidence during audits or regulatory inquiries.

    FAQ: Can our site request a log export for only one user?

    Yes. Use the filter tools in the Audit Log panel to generate reports by user role, action type, or date.

    Which Actions Are Tracked?

    The platform logs and preserves all material interactions related to trial management and participant engagement, including but not limited to:

    Action TrackedExamples
    User login and session activityLogin time, logout, failed attempts
    Trial creation or status updatesMarking a study as Live, Paused, Closed
    Participant match viewingWhich user viewed which match and when
    Consent progress loggingStatus changes, notes added
    Document uploadsIRB forms, eligibility criteria
    Participant communicationContact attempts, message timestamps
    User permission changesRole assignment, deactivation, reassignments
    Data exports or report generationMatch CSV exports, dashboard PDF downloads

    Each log entry contains:

    • Timestamp (UTC)
    • User ID and role
    • Site name and trial ID
    • Action type
    • Device metadata (e.g., IP address)

    Where to Access Audit Logs

    Site Administrators have full access to their site’s audit logs through the Compliance & Reporting Panel in their dashboard.

    • Navigate to Dashboard → Compliance → Audit Logs
    • Apply filters (date range, user role, trial ID)
    • Export reports (CSV, JSON, PDF)
    • Downloadable logs include platform watermark and authentication hash

    All logs are encrypted at rest and in transit. Logs are retained in compliance with HIPAA (minimum 6 years) and can be extended to meet sponsor or IRB-specific retention policies.

    Why Audit Trails Matter

    Audit trails:

    • Support regulatory readiness: Required by FDA, OHRP, and IRB bodies
    • Protect participant safety: Detect unusual access or communication patterns
    • Reduce compliance risk: Enable proactive review before issues arise
    • Ensure internal accountability: Hold staff and collaborators to SOP-aligned practices

    Best Practices for Sites

    • Review logs regularly during high-volume recruitment periods
    • Assign access based on minimum-necessary permissions
    • Escalate anomalies (e.g., data viewed outside working hours, access by wrong role)
    • Document corrective actions taken in response to any discrepancies

    If a user error or protocol deviation is detected via logs, report it immediately to your IRB and DecenTrialz Support.

    Key Note: Audit trails are not just a backend function,  they are your first line of defense in regulatory inspections. Proper use demonstrates transparency, preparedness, and ethical commitment to participant protection. All site staff should be trained to understand the role of audit logs and their implications.

  • Viewing Matches

    Once a trial is listed and live on the DecenTrialz platform, eligible participants who complete the pre-screening process may be algorithmically matched to that study. This section explains how site personnel, under the supervision of the Site Administrator, can view and manage participant matches in a secure, compliant, and auditable manner.

    What Is a Match?

    A “match” occurs when a participant’s pre-screening responses align with the basic inclusion/exclusion criteria set by your site during trial setup. A match indicates that the participant may be eligible and has shown interest in learning more about your study. However, final eligibility must still be determined through your site’s standard screening and consent process.

    Note: DecenTrialz only facilitates pre-screening and referral. It does not make medical determinations or replace site-level screening.

    Who Can View Matches

    Only authorized site personnel with one of the following roles may access the Match Dashboard:

    User RoleAccess Permissions
    Site AdministratorFull access to all matches, filters, and exports
    Principal InvestigatorView participant data for trials they are assigned to
    Study CoordinatorView, filter, respond to, and document match actions
    Regulatory StaffNo access to participant data
    Viewer (Read-Only)View-only access, no interaction or logging rights

    All user activity is logged and timestamped for audit purposes.

    Example Workflow by Role

    • Site Admin: Logs in daily to review all new matches, assigns team leads.
    • Study Coordinator: Filters for matches by date, logs outreach, and updates status.
    • PI: Reviews final referral list before screening begins.

    Where to View Matches

    Matches can be accessed via the “Match Dashboard”, which is available under the “Participants” tab of each trial listing. The dashboard displays:

    • Participant initials or anonymized ID
    • Match status (New, Reviewed, Action Taken)
    • Date of match and time of pre-screener completion
    • Key matching tags (e.g., age range, condition match, location proximity)
    • Communication status (e.g., outreach pending, in progress, completed)

    No sensitive identifiers (e.g., full name, contact info) are shown until the site confirms interest and data-sharing compliance.

    Filtering and Sorting Options

    To streamline your workflow, the Match Dashboard offers advanced filtering by:

    • Match date
    • Trial arm (if applicable)
    • Eligibility confidence score (based on pre-screener accuracy)
    • Participant proximity (by ZIP/postal code or region)
    • Outreach status (not contacted, contacted, declined, referred)

    These filters help prioritize outreach efforts and ensure timely follow-up.

    Best Practices for Reviewing Matches

    1. Check daily for new matches: Especially during active recruitment windows.
    2. Prioritize high-probability matches: Use filters to target participants meeting multiple core criteria.
    3. Document all review actions: Whether proceeding, declining, or requesting additional info, all actions must be logged.
    4. Coordinate internally: Assign matches to appropriate site staff using built-in assignment tools.

    Data Security and Access Control

    • All match data is stored on HIPAA-compliant, access-controlled servers.
    • Participants remain anonymous until your site formally opts to initiate outreach.
    • Match data must not be downloaded or stored externally unless authorized under your institution’s data policy and participant consent provisions.
    • Any suspected misuse or unauthorized access must be reported immediately to DecenTrialz Support.

    Audit-Ready Logs and Reporting

    • All user activity on the Match Dashboard is timestamped and linked to platform user IDs.
    • Site administrators can export match logs (CSV or PDF) for internal records or sponsor reporting.
    • All exports are watermarked and include metadata for audit traceability.

    Key Note: Viewing a participant match is the beginning,  not the end of the engagement process. Sites must follow up ethically, respectfully, and in accordance with IRB-approved communication templates and consent policies. Misuse of match data or failure to document outreach may result in platform-level compliance action.

  • Who Can Register as a Site

    To ensure participant safety, ethical oversight, and regulatory alignment, only verified and qualified research organizations may register as sites on the DecenTrialz platform. Registration grants access to tools for managing clinical trials, receiving pre-screened participants, and maintaining compliance across the trial lifecycle.

    This section outlines which types of institutions are eligible to register, who is not permitted to register, what baseline requirements must be met, and how DecenTrialz evaluates site-level readiness before access is granted.

    Overview: Who Qualifies as a Research Site

    A research site is defined as a physical or virtual location that conducts one or more components of a clinical trial, under the direction of a licensed Principal Investigator (PI), and with oversight by an Institutional Review Board (IRB) or Ethics Committee.

    To qualify for registration on DecenTrialz, an organization must:

    • Be legally registered in its operating jurisdiction
    • Be capable of conducting human subject research under GCP
    • Be affiliated with at least one licensed PI
    • Be covered by IRB or equivalent ethical oversight

    Eligible Entity Types

    The following categories of organizations are considered eligible for site registration:

    1. Academic Medical Centers

    Universities, medical colleges, and affiliated research hospitals that operate formal clinical trial units or research departments. These institutions often conduct both investigator-initiated and sponsor-supported studies.

    Examples include:

    • University hospitals with clinical research offices
    • Teaching hospitals with PI-led trials
    • NIH-funded academic research consortia

    2. Independent Research Clinics / Private Trial Units

    Privately owned research centers that specialize in clinical trials across one or more therapeutic areas, and that maintain their own IRB affiliations or use a central IRB.

    Examples include:

    • Standalone clinical trial sites with dedicated CRCs
    • Community-based research clinics

    Note: Must provide proof of GCP adherence, PI oversight, and ethical governance.

    3. Hospital-Based Research Departments

    Specialty or general hospitals that maintain in-house research programs. These may be part of a larger health system or independently operated but must demonstrate:

    • Research-specific infrastructure
    • Staff training in clinical trial operations
    • Protocol management processes

    4. Site Management Organizations (SMOs)

    Organizations that manage multiple research sites under centralized administration. SMOs may register individual sites under a network structure or request umbrella access with linked sub-sites.

    Requirements include:

    • Documentation of site relationships
    • Central IRB usage where applicable
    • Oversight structure for sub-site activity

    5. Integrated Research Networks / Investigator Groups

    Multi-location research groups or collaborative physician networks conducting decentralized, community-based, or hybrid trials. Must designate a lead administrative site and PI.

    Baseline Requirements for Site Registration

    Every entity must meet the following minimum standards:

    RequirementDescription
    Legal RegistrationMust be a recognized business entity with a valid Tax ID, EIN, or local equivalent
    Principal Investigator (PI)One or more licensed PIs responsible for trial oversight and participant safety
    IRB or Ethics ApprovalValid affiliation with a central or local IRB/EC with documentation on file
    Data Security CapabilityMust be capable of storing and managing participant data in accordance with HIPAA, GCP, and relevant local regulations
    Designated Site AdministratorOne individual accountable for platform access, user permissions, and document maintenance

    Accountability and Oversight Expectations

    Upon approval, each research site is expected to:

    • Operate in accordance with ICH-GCP guidelines
    • Maintain accurate credentials and IRB documents
    • Assign qualified staff to platform-based workflows (e.g., pre-screening follow-up, referral tracking)
    • Ensure communication with participants is ethically appropriate and IRB-compliant
    • Cooperate with platform-based audits or data verification processes when required

    Who Can’t Register as a Site?

    The following groups or individuals are not permitted to register as sites:

    Ineligible ApplicantReason
    Individual investigators without site affiliationPlatform requires organizational accountability and IRB governance
    Contract staff, consultants, or freelancersLack of institutional oversight, unclear responsibility chain
    CROs or Sponsors acting as their own sitesConflicts of interest; platform separates sponsor and site functions
    Sites without IRB oversightAll participant referrals must be governed by IRB-approved protocol and safety procedures
    Unlicensed facilities or pop-up unitsShould meet applicable state and national regulations to qualify for ethical research participation for human subject research

    Note: Any attempt to register using falsified information or without meeting the above criteria may result in permanent suspension from the platform.

    Key Note: If you’re unsure whether your site qualifies, you may contact DecenTrialz Support at support@decentrialz.com with your credentials for a preliminary check. We encourage early engagement before formal application.

    Multi-Site or Networked Sites

    Organizations that operate across multiple locations may request centralized account access with sub-site configurations. Approval will depend on:

    • Documentation of relationship between central and satellite locations
    • IRB coverage for each location or shared protocol
    • Appointment of sub-site administrators with clearly defined permissions

    Key Note: Site registration is not simply a technical step; it is a regulatory commitment. Only entities that demonstrate ethical, legal, and clinical readiness to engage in human subject research are permitted to operate on the DecenTrialz platform. Our team reviews each application carefully to protect the integrity of the research ecosystem and the rights of participants.

  • Cross-border Data Transfer

    In today’s global clinical research landscape, some trials involve international collaboration, meaning your data may be securely transferred across borders for analysis, regulatory submission, or scientific review. This process is known as cross-border data transfer, and it is strictly regulated to protect your privacy.

    What Is Cross-border Data Transfer?

    Cross-border data transfer refers to:

    • Moving your personal or health-related data from one country to another
    • Sharing data between international sponsors, research organizations, or regulatory bodies
    • Hosting your data in secure servers located outside your home country

    This may happen if:

    • The sponsor or research institution is based in another country
    • A trial uses centralized global systems for data collection and analysis
    • External labs or regulatory authorities review the results

    Is It Safe and Legal

    Yes, but only when strict data protection rules are followed. At DecenTrialz, all cross-border data sharing:

    • Requires your explicit, informed consent
    • Complies with international privacy laws such as HIPAA (USA), GDPR (EU), and local country laws
    • Ensures that data is de-identified or pseudonymized before transfer
    • Is governed by Data Transfer Agreements (DTAs) between institutions that define usage and access limits

    Key Note: If your data is shared internationally, the consent form will clearly explain where it’s going, why, and what privacy laws apply.

    How Is My Privacy Maintained?

    We use multiple layers of protection to ensure your personal information is secure:

    • All data is encrypted during transfer and at rest
    • Only authorized personnel can access identifiable information, and only if needed
    • Your data may be coded or anonymized so researchers see only reference numbers, not names or contact details
    • Data storage partners must meet global cybersecurity standards

    Can I Say No to Cross-border Transfer?

    Yes. If a trial involves international data sharing:

    • You will be informed ahead of time
    • You may choose not to participate in that trial if you are uncomfortable with cross-border transfer
    • Your decision will not affect your eligibility for other studies

    Key Note: Participation is always voluntary, and that includes decisions about how and where your data is used.

  • Genetic Data and Sensitive Information

    Some clinical trials, particularly those related to rare diseases, cancer, or personalized medicine, may request access to your genetic data or other highly sensitive personal information. Because of the deeply private nature of this data, strict ethical, legal, and technical safeguards are in place.

    What Is Genetic Data?

    Genetic data refers to information obtained from:

    • DNA testing
    • Whole genome or exome sequencing
    • Saliva or blood samples used to analyze your inherited traits

    This data can help researchers understand:

    • How certain genes affect diseases
    • Why some treatments work better for certain individuals
    • How to develop more targeted therapies

    Why Is It Sensitive?

    Genetic data is considered highly sensitive because it:

    • Can reveal information about your health risks
    • May also reveal information about your biological relatives
    • Does not change over time (unlike weight or blood pressure)
    • May be used to study ancestry, identity, or predispositions

    Key Note: You are never required to share your genetic data to join a trial unless it’s a core requirement, and you must be fully informed beforehand.

    How Is It Protected?

    If a study requests genetic data:

    • You will receive a separate consent form explaining how the data will be used
    • The data will be de-identified wherever possible before analysis
    • Only authorized, IRB-approved researchers will have access
    • The data will be stored in secure, encrypted environments
    • In many cases, data may be used for research purposes only, not for diagnosis

    Additionally:

    • You can request your sample be destroyed after use
    • You can decline to have your genetic data shared with outside institutions

    Will My Genetic Data Be Shared With Insurance or Employers?

    No. In the United States of America, your genetic data is protected under laws such as:

    • HIPAA (Health Insurance Portability and Accountability Act)
    • GINA (Genetic Information Nondiscrimination Act)

    These laws make it illegal for health insurers or employers to use your genetic data against you.

    Key Note: Any clinical trial using genetic data must include full disclosures and obtain your specific, separate, and voluntary consent.

  • Ethics and Oversight

    Clinical research must follow strict ethical guidelines to protect participants and maintain public trust. These protections are enforced through multiple levels of oversight, from Institutional Review Boards (IRBs) to national and international regulatory bodies. This section explains how your safety and rights are safeguarded throughout the process.

    Role of IRB in Protecting You

    An Institutional Review Board (IRB), sometimes called an ethics committee, is an independent group responsible for reviewing and approving research involving people.
    Their job is to ensure that:

    • The study’s risks are minimized and clearly communicated
    • The benefits (if any) outweigh potential harms
    • Participant rights and welfare are fully protected
    • The informed consent process is fair, transparent, and comprehensive

    No trial involving human participants can begin without IRB approval.

    Key Note: Every study listed on DecenTrialz must be IRB-approved before it’s shared with potential participants.

    Monitoring for Safety

    Once a study begins, participant safety is monitored by:

    • The research team conducting the trial
    • An IRB or Ethics Committee, which reviews ongoing data
    • Sometimes a Data and Safety Monitoring Board (DSMB), an independent group that periodically evaluates the study’s safety data and outcomes

    They monitor for:

    • Serious side effects or unexpected outcomes
    • Whether the benefits still outweigh the risks
    • Whether the study should continue, be modified, or stop early

    If any concerns arise, the study can be paused or ended immediately.

    Key Note: You have the right to be notified if new information arises that could affect your decision to stay in the trial.

    Reporting Misconduct or Concerns

    If something doesn’t feel right during the trial, if you feel uncomfortable, unsafe, or believe the study isn’t following proper procedures, you have the right to report it.

    You can report concerns to:

    • The research team directly
    • The IRB that approved the study (their contact info is often listed on the consent form)
    • A patient advocacy group
    • Or, if needed, regulatory authorities like the FDA (in the United States of America)

    Reports may include:

    • Being pressured to stay in the trial
    • Not being told about new risks
    • Feeling unsafe or not being treated respectfully
    • Believing your data is being mishandled

    Key Note: Reporting a concern will never affect your medical care or your right to participate in other studies in the future.

  • Informed Consent

    Informed consent is a cornerstone of ethical clinical research. It ensures that every participant enters a trial with full understanding, free will, and the ability to make their own decisions. At DecenTrialz, we support informed consent as a process, not just a form.

    What Is Informed Consent?

    Informed consent is the formal process by which you learn about the key aspects of a clinical trial before deciding to participate.

    You will receive a document that clearly explains:

    • The purpose of the study
    • The procedures and schedule
    • Potential risks and benefits
    • Your rights as a participant
    • How your data will be used
    • Whom to contact with questions

    It is not just a signature, it is a conversation. You must have the opportunity to ask questions and get clear answers before signing.

    Key Note: No one can include you in a clinical trial without your explicit, voluntary consent. It is your legal and ethical right.

    Who Explains the Consent?

    The consent process is usually explained by:

    • A research coordinator, nurse, or physician at the study site
    • A trained member of the research team who is familiar with the trial and qualified to answer questions

    They are responsible for making sure:

    • You fully understand the document
    • You feel no pressure to sign
    • You are aware you can say no at any time

    Key Note: If English is not your preferred language, you have the right to request a translated form or an interpreter.

    Updating or Revoking Consent

    Your consent is not permanent or binding. You may:

    • Withdraw your consent at any time
    • Ask to stop certain parts of the study
    • Request changes in how your data is used going forward

    If a trial changes significantly after you’ve joined (e.g., a new procedure or risk is added), you must be re-informed and asked to sign an updated consent form.

    Key Note: You are never locked into a trial. Consent is ongoing, you are always in control.

    Can I Take the Form Home?

    Yes. You can and should take the consent form home before signing it.

    This gives you time to:

    • Read it carefully
    • Discuss it with family, friends, or your personal doctor
    • Prepare any questions you want to ask the research team

    You should never feel rushed to sign on the spot.

    Key Note: The decision to join a trial is personal. Take the time you need, your comfort and confidence matter.

    What If I Don’t Understand It?

    If anything in the consent form is unclear:

    • Ask the research staff to explain it again in simpler terms
    • Request written summaries or diagrams
    • Involve someone you trust to help you review it

    You have the right to full understanding, not just basic agreement.

    Key Note: Never sign a consent form unless you feel completely informed. The research team is required to support you in this.

    Common Questions About Consent

    Some of the most frequently asked questions include:

    Q: Can I change my mind after signing the consent form?
    A: Yes. You can withdraw from the study at any time without penalty.

    Q: What happens to my data if I withdraw consent?
    A: Data collection stops immediately from the moment you withdraw. However, to protect the scientific integrity of the study, data that was already collected may still be included in the final de-identified analysis. This will be clearly explained in your consent form.

    Q: Will I receive a copy of the form I signed?
    A: Yes, you will receive a printed or digital copy of the signed consent form for your records.

    Q: What if I feel pressured to sign?
    A: That is not allowed. Trials must be voluntary, and you can report any pressure or misconduct to the research site or an ethics board.

    Q: Can I ask more questions after signing?
    A: Absolutely. Informed consent is ongoing, you can ask questions at any time during the trial.

  • Data Privacy and HIPAA

    Understanding how your data is collected, stored, shared, and protected is a fundamental part of participating in any clinical research study. At DecenTrialz, we take privacy extremely seriously and operate in full alignment with the Health Insurance Portability and Accountability Act (HIPAA) and ISO 27001.

    What Data is Collected

    When you sign up on DecenTrialz and complete the pre-screening process, the platform collects certain types of data to help match you with appropriate clinical trials.

    This may include:

    • Basic personal details (e.g., age, gender, zip code)
    • Contact information (e.g., phone, email)
    • Medical history (e.g., past diagnoses, medications)
    • Lifestyle or health behavior data (e.g., smoking, activity levels)
    • Location preferences for trial participation
    • Eligibility-specific answers to pre-screening questions

    Key Note: You control what data you share. Only the minimum necessary data is collected to help match you to suitable studies.

    How Data is Stored and Secured

    All data entered into DecenTrialz is:

    • Encrypted during transmission and at rest
    • Stored securely in HIPAA-compliant servers, which are primarily located in the United States.
    • Access-controlled so only authorized personnel or systems can use it

    We follow industry best practices and undergo periodic security audits to ensure ongoing protection of your personal information.

    What we never do:

    • We never sell your data.
    • We never share your name or contact without your permission.
    • We never use your data for purposes unrelated to research matching.

    Key Note: You can request a copy or deletion of your stored data at any time, in compliance with HIPAA and other global regulations.

    Who Can See Your Data

    Your data is only visible to:

    • Authorized DecenTrialz support and tech teams (for matching and support purposes)
    • Research sites only after you’ve matched and with your knowledge
    • In some cases, a Clinical Research Organization (CRO) or sponsor, but only in de-identified or aggregated form unless you’ve explicitly consented

    What is de-identified data?
    This means your name, contact details, and other identifying information are removed so your data cannot be traced back to you.

    Key Note: If your profile is referred to a research site, you will always be informed before any identifiable data is shared.

    HIPAA Compliance Overview

    HIPAA stands for the Health Insurance Portability and Accountability Act, a federal law in the United States of America that sets the standard for protecting sensitive health data.

    As a HIPAA-compliant platform, DecenTrialz ensures:

    • You are informed about how your data is used
    • You have the right to access and control your health information
    • Only authorized entities may access your identifiable data
    • Your data is encrypted and securely stored

    Our team is trained in HIPAA regulations, and we work only with research partners who follow similar ethical and legal standards.

    Key Note: Participation in clinical trials through DecenTrialz does not affect your health insurance. HIPAA protects your data both during and after your use of our platform.